PARP superfamily members also contribute to the host inflammatory and immune responses to viral infection. PARP-1 functions as a coactivator of NF-κB 27, 28 , a function for which the PARP enzymatic activity does not seem to be required. PARP-9 (BAL1), which lacks PARP activity 29 and is inducible by interferon-γ (IFN-γ), is able to increase the expression of interferon-stimulated genes 30 , which suggests a putative role in the host defense against viral infection. However, the role of PARP superfamily members in the activation of innate signaling pathways mediated by PRRs such as RIG-I is not clearly understood.
Here we show that the shorter isoform of PARP-13 (ZAPS), rather than the full-length isoform (ZAP), was selectively induced by 3pRNA and functioned as a regulator of RIG-I-mediated signaling. Knockdown experiments show that ZAPS had a role in the induction of type I interferon genes in various human cell lines and human primary cells. Mechanistically, ZAPS directly associated with RIG-I in a ligand-dependent manner to efficiently promote the oligomerization of RIG-I, which resulted in much greater ATPase activity of RIG-I and subsequently enhancement of activation of the downstream IRF3 and NF-κB signaling pathways. Consistent with those results and data based on zinc-finger nuclease (ZFN)-mediated gene disruption, ZAPS strengthened the RIG-I-mediated induction of type I interferons and other inflammatory cytokines and inhibited viral replication after infection with RNA viruses that involve RIG-I, such as influenza virus and Newcastle disease virus (NDV). Our findings indicate that ZAPS has an important role as a potent stimulator of RIG-I signaling in the innate immune response to viral infection.
RESULTS

Contribution of PARPs to the interferon response
To investigate the role of the PARP-superfamily members in nucleic acid-induced innate immune responses, we chose to study some of the PARP superfamily members known to be involved in microbial infection, inflammation and immunity, including PARP-1, PARP-2, PARP-7, PARP-9, PARP-12 and PARP- 13 (refs. 19,23,31-34) . We then determined whether they were able to enhance the induction of IFN-β mRNA in HEK293T human embryonic kidney cells in response to stimulation with the following three different types of nucleic acids: 3pRNA; the synthetic double-stranded RNA polyinosinic-cytidylic acid (poly(rI:rC)); and the synthetic B-form double-stranded DNA poly(dA-dT)•poly(dA-dT) (poly(dA:dT)). Among the proteins tested, PARP-13 uniquely showed a substantial enhancement effect on the expression of IFN-β mRNA induced by stimulation with 3pRNA, poly(rI:rC) or poly(dA:dT) (Fig. 1a) , each of which is known to activate the RIG-I-mediated pathway in HEK293T cells 9, 10, [35] [36] [37] . We also detected slightly more IFN-β mRNA expression in cells expressing PARP-1, PARP-2 and PARP-9. PARP-13 exists in at least two isoforms 22, 26, 38 . The amino-terminal 254-amino acid fragment of the rat PARP-13 homolog, which corresponds to the amino-terminal one-third portion of the shorter isoform of human PARP-13 protein, has been identified as rNZAP (rat N-terminal zinc finger antiviral protein) 20 . The expression of rNZAP results in specific decay of viral mRNA without any effect on the amount of mRNA derived from host cells 20, 39 . However, the role of human PARP-13 in the induction of type I interferon remains unknown.
We first examined the role of the two PARP-13 isoforms in the induction of type I interferon by 3pRNA. Each isoform enhanced the induction of IFN-β mRNA and activation of the IFNB promoter after stimulation with 3pRNA (Fig. 1b) . However, the shorter form of PARP-13 (isoform 2; ZAPS), which lacks the PARP domain, had a greater effect than did full-length PARP-13 (isoform 1; ZAP; Fig. 1b) . This indicates that interferon induction does not necessarily require the PARP domain of PARP-13. Consistent with those observations, ZAPS mRNA was induced exclusively by stimulation with 3pRNA in both HEK293T cells and human primary CD14 + monocytes purified A r t i c l e s from peripheral blood mononuclear cells, whereas full-length ZAP was constitutively expressed but was barely induced (Fig. 1c, left, d) .
The promoter region of the gene encoding ZAP (ZC3HAV1) contains interferon-stimulated response elements and IRF-binding elements 40 .
We investigated whether expression of ZAPS and ZAP is regulated by similar mechanisms. Treatment with IFN-α resulted in the induction of ZAPS but not of full-length ZAP (Fig. 1c, right) . These data suggest that the mechanism of ZAPS induction differs from that of ZAP induction and indicate a distinct role for ZAPS as a regulator of innate immunity. Therefore, we focused on the function of ZAPS in RIG-I signaling.
ZAPS enhances RIG-I-mediated production of type I interferon Next we examined the effect of ZAPS in RIG-I-mediated induction of type I interferon. Expression of ZAPS in HEK293T cells markedly enhanced the 3pRNA-induced expression of IFN-α1 and IFN-α4 mRNA as well as IFN-β mRNA (Fig. 2a) . The enhancement of IFN-β mRNA induction correlated positively with ZAPS overexpression (Fig. 2b) . Consistent with that result, 3pRNA induced activation of the IFNB promoter in a manner dependent on the amount of ZAPS expression in HEK293T cells ( Fig. 2c and Supplementary Fig. 1a ).
We observed activation of genes encoding type I interferons and interferon-related genes even in the absence of 3pRNA stimulation (Fig. 2b,c and Supplementary Fig. 1b) . In contrast, ZAPS did not have a positive effect on a luciferase reporter responsive to the transcription factor E2F or driven by the serum response element ( Supplementary  Fig. 1c ) or on the induction of E2F target genes and serum response element-dependent genes (Supplementary Fig. 1b) .
To further evaluate the contribution of ZAPS to the RIG-I signaling, we used an RNA-mediated interference approach. Notably, each small interfering RNA (siRNA) targeting a different site of ZAPS mRNA (siZAPS1, siZAPS2 and siZAPS3) knocked down the expression of endogenous ZAPS protein and ZAPS mRNA ( Supplementary Fig. 2a,b) , which resulted in significant suppression of 3pRNA-induced expression of IFN-β mRNA in HEK293T cells (Fig. 2d, left) . Knockdown with siZAPS3 also resulted in significant inhibition of the production of IFN-β protein in response to 3pRNA stimulation, as assessed by enzyme-linked immunosorbent assay (ELISA; Fig. 2d, right) . Furthermore, the knockdown effect of siZAPS3 could be 'rescued' by the expression of mouse ZAPS that does not carry the target sequence for siZAPS3 (Fig. 2e) but not by the expression of another PARP superfamily member, PARP-1, which did not significantly affect 3pRNA-induced expression of IFN-β mRNA (Figs. 1a and 2e) . We also examined the effect of siZAPS3 knockdown in the following additional cell types: the A549 human lung epithelial adenocarcinoma cell line, the HeLa cervical cancer cell line and the THP-1 acute monocytic leukemia cell line. The induction of IFN-α and IFN-β mRNA in response to 3pRNA or to viral RNA derived from influenza virus was abrogated by knockdown of endogenous ZAPS protein with siZAPS3 ( Fig. 2f, Supplementary Fig. 2c,d and data not shown). Furthermore, the type I interferon response to 3pRNA was significantly suppressed by knockdown of ZAPS in human primary CD14 + monocytes ( Fig. 2g) and fibroblasts ( Fig. 2h) , which indicates the physiological importance of ZAPS in human cells. These results suggest that ZAPS is a potent stimulator of the RIG-I-mediated type I interferon response.
ZAPS facilitates NF-B and IRF3 signaling
We next investigated whether ZAPS can enhance NF-κB and IRF3 signaling downstream of RIG-I. The induction of genes encoding other A r t i c l e s cytokines, such as tumor necrosis factor (TNF), interleukin 6 (IL-6) and the chemokine CXCL10, in response to stimulation with 3pRNA was diminished in A549 cells in which ZAPS was knocked down (Fig. 3a) . This suggests that ZAPS also activates the NF-κB pathway, another important signaling branch of the RIG-I-mediated pathway. Consistent with that idea, ZAPS overexpression in HEK293T cells induced robust activation (13-fold) of an NF-κB-responsive promoter after stimulation with 3pRNA (Fig. 3b) . However, ZAPS had a lower activating effect on the NF-κB-responsive promoter after stimulation of TLR8 by the synthetic imidazoquinoline resiquimod (R-848; Fig. 3c ). Dimerization of IRF3 (a transcription factor essential for RIG-I-mediated production of type I interferon) induced by 3pRNA was much lower in HEK293T cells pretreated with siZAPS3 (Fig. 3d) . In addition, electrophoretic mobility-shift assay showed that NF-κB activation in response to stimulation with 3pRNA was inhibited in HEK293T cells pretreated with siZAPS3 (Fig. 3e) . Collectively, these data indicate that ZAPS may be an essential component of the RIG-Imediated signaling pathway, affecting activation of both the IRF3-and NF-κB-activation pathways.
Activation of RIG-I transmits signals to the adaptor protein MAVS, which leads to the activation of TBK1, one of the IRF3 kinases 6, 7 . STING (also known as TMEM173, MITA, ERIS or MPYS), a signaling mediator possibly situated downstream of MAVS, can activate both the NF-κB and IRF3 pathways 15, 41 . As TBK1 can activate only the IRF pathway after stimulation with cytosolic RNA 6, 7, 15 , we speculated that ZAPS may function upstream of TBK1. Indeed, the expression of IFN-β mRNA induced by exogenous expression of ZAPS in HEK293T cells was abolished by siRNA-mediated downregulation of TBK1 (Supplementary Fig. 3) . Notably, ablation of not only STING or MAVS but also RIG-I in HEK293T cells, achieved by RNA-mediated interference, inhibited ZAPS-mediated expression of IFN-β mRNA (Fig. 3f) . These results suggest a role for ZAPS as a proximal regulator of RIG-I-mediated signaling.
Interaction of ZAPS with RIG-I
To gain insight into how ZAPS functions as a potentiator of RIG-I activation, we determined whether ZAPS interacts with RIG-I. Confocal analysis of HeLa cells transfected with yellow fluorescent protein (YFP)-tagged ZAPS and Flag-tagged RIG-I showed that these two proteins localized together with each other mainly in the cytoplasm 4 h after stimulation with 3pRNA (Fig. 4a) . In addition, we detected a fluorescence resonance energy transfer (FRET) signal in the cytoplasmic perinuclear space after stimulation with 3pRNA (Fig. 4b) . These results indicate that ZAPS interacts directly with RIG-I after ligand stimulation. In an immunoprecipitation assay, the interaction between ZAPS and RIG-I recombinant proteins produced in Escherichia coli was enhanced in the presence of viral RNA (Supplementary Fig. 4a) . In HEK293T cells expressing hemagglutinin-tagged (HA-tagged) ZAPS and Flag-tagged RIG-I, the interaction between the two proteins was enhanced after stimulation with 3pRNA or viral RNA (Fig. 4c, left, and Supplementary Fig. 4b) , and we similarly observed such a ZAPS-RIG-I interaction after infection with NDV (Fig. 4c, middle) . We confirmed that endogenous ZAPS protein associated with endogenous RIG-I in MRC-5 human fibroblasts and A549 cells (Fig. 4c, right, and Supplementary Fig. 4c) .
We also determined that the carboxy-terminal region of RIG-I (amino acids 218-925) but not its CARDs (amino acids 1-284) was required for interaction with ZAPS (Fig. 4d) . In addition, the carboxy-terminal region of RIG-I, but not full-length RIG-I, 'preferentially' interacted with ZAPS even in the absence of 3pRNA stimulation (Fig. 4d) , which suggested that the activation-induced conformational change of RIG-I may be necessary for its interaction with ZAPS. However, ZAPS did not bind to either the helicase domain or the carboxy-terminal domain of RIG-I alone (Supplementary Fig. 4d ). Both of those domains seemed to be required for the interaction with ZAPS. In contrast, full-length ZAPS coimmunoprecipitated with the carboxy-terminal region of RIG-I, but a truncated ZAPS lacking all four of the zinc fingers in its amino-terminal region (ZAPSΔzf) did not (Fig. 4e) , which suggested that ZAPS binds to RIG-I via the zinc fingers. In addition, surface plasmon resonance-based analysis of recombinant ZAPS and RIG-I showed that ZAPS interact with RIG-I even in the absence of 3pRNA, with an affinity in the nanomolar range (dissociation constant, 116 nM; Supplementary Fig. 4e ), but it failed to enhance the binding of RIG-I to 3pRNA (data not shown). We next determined whether ZAPS is involved in RIG-I activation. We first examined the involvement of ZAPS in 3pRNA-or virusinduced RIG-I dimerization or oligomerization, which is important in activation of the downstream signaling pathway for interferon production [42] [43] [44] . The formation of RIG-I oligomers induced by 3pRNA or NDV was diminished in HEK293T cells with downregulated expression of ZAPS ( Fig. 4f and Supplementary Fig. 4f ). These data suggest that ZAPS regulates RIG-I oligomerization for the subsequent robust activation of RIG-I signaling. In vitro biochemical analysis demonstrated that the 3pRNA-induced ATPase activity of purified recombinant RIG-I was much greater in the presence of recombinant ZAPS but not in the presence of ZAPSΔzf (Fig. 4g) . We further found that the association of RIG-I with its adaptor MAVS was substantially attenuated in HEK293T cells treated with siZAPS3 (Fig. 4h) . These findings suggest that ZAPS associates with RIG-I to positively modulate the oligomerization and activation of RIG-I.
Role of ZAPS in infection with RNA viruses
To further evaluate the function of ZAPS in RIG-I-mediated antiviral responses, we infected A549 cells with influenza virus, which activates RIG-I-mediated innate signaling 10, 45 . We found that siRNAmediated knockdown of ZAPS expression impaired the induction of IFN-β and IFN-α1 mRNA ( Fig. 5a and Supplementary Fig. 5a ) and IFN-β protein (Fig. 5b) in response to infection with influenza virus (strains A/X-31 (H3N2) and A/Aichi/2/1968 (H3N2)). The induction of IL-6, TNF and CXCL10 was also lower (Fig. 5a) . Expression of the viral nucleoprotein was not affected by siRNA-mediated knockdown of ZAPS in the early phase of infection ( Supplementary  Fig. 5b ). However, we detected approximately sevenfold more of the viral nucleoprotein gene in siZAPS3-treated A549 cells at 72 h after infection with influenza virus (A/X-31) than in A549 cells (Fig. 5c) . Moreover, exogenous expression of ZAPS in HEK293T cells resulted in increased induction of IFN-β mRNA after infection with influenza virus, accompanied by considerable suppression of viral replication (Fig. 5d) . We also obtained similar results after infection with NDV ( Fig. 5e-g ), another single-stranded RNA virus also known to induce type I interferon responses via RIG-I (refs. 4, 45) . Our data suggest that ZAPS exerts its antiviral activity mainly by interactions with the RIG-I-mediated type I interferon pathway (Supplementary Fig. 5c ), although the possibility of an indirect effect on viral replication cannot be completely ruled out.
ZAPS mediates RIG-I activation in human cells
To further confirm the critical role of ZAPS in human cells, we used a ZFN approach [46] [47] [48] for site-specific disruption at the targeted site in exon 3 of ZC3HAV1, the gene encoding endogenous PARP-13 ( Fig. 6a) . We established two ZC3HAV1-knockout clones derived from multiploid HEK293T cells. Genome sequence analysis showed that clone 32 and clone 89 had the following distinct mutations in isoform 2 of ZC3HAV1 (GenBank accession number NM_024625.3): clone 32, c.1023_1047del25insGTT, c.1027_1046del20, c.1031_1032insATCCA and c.1033_1034insCAATC; clone 89, c.1035_1036insTCCA, c.1023_ 1047del25insGTT and c.1027_1046del20. All these mutations abolished the expression of functional protein (Fig. 6b) . In these two genetically distinct knockout clones, NDV infection failed to induce the expression of mRNA for IFN-β and other cytokines (Fig. 6c) . IFN-β expression induced by 3pRNA was similarly inhibited in both clone 32 and clone 89, and this phenotype was 'rescued' by exogenous expression of ZAPS (Fig. 6d) . These results suggest that ZAPS has a crucial role in RIG-I-mediated gene induction. 
DISCUSSION
The PARP superfamily has important roles in many biological and pathological processes. Some members of the PARP superfamily are known to directly regulate viral gene expression and replication. However, the role of the PARP superfamily in host immune responses mediated by innate sensors has remained unknown. In this study we have demonstrated that PARP-13 was a regulator of RIG-I-mediated antiviral signaling in human cells. We also found that ZAPS, the shorter isoform of PARP-13 (ZAP), was selectively upregulated by treatment with 3pRNA, possibly through type I interferon signaling. In this context, it has been speculated that ZAPS may act as a positive feedback regulator in RIG-I-mediated induction of type I interferon genes. Consistent with that scenario, the promoter of the gene encoding ZAP (and ZAPS) contains interferon-stimulated response elements and IRF-binding elements. How each isoform is regulated differently remains unclear.
Activation of RIG-I by 3pRNA leads to its association with MAVS and activation of the cytosolic protein kinases IKK and TBK1, which in turn activate the transcription factors NF-κB and IRF3 or IRF7, respectively 6, 15 . RIG-I activation after ligand binding is thought to be a multistep process that includes the activation of its ATPase activity, conformational changes and oligomerization 42, 43 . Our data have demonstrated that ZAPS interacted with RIG-I after stimulation with 3pRNA and potently enhanced the ATPase activity and oligomerization of RIG-I, possibly by stabilizing the RNA-RIG-I complex, although the underlying mechanism needs to be investigated further. Consistent with that, ZAPS robustly enhanced downstream geneexpression programs mediated by RIG-I-MAVS, including those of genes encoding type I interferons and proinflammatory cytokines. However, our results also indicated that ZAPS expression alone slightly enhanced the expression of IFN-β mRNA and activation of the IFNB promoter independently of any ligand or other stimuli. Consistent with those data, we detected the ZAPS-RIG-I interaction before stimulation, although it was very weak. This disconnection of ligand dependence suggested that the ZAPS-RIG-I interaction was sufficient to promote small amounts of signaling but that the overall signaling program was most efficiently triggered by the binding of ligand to RIG-I in addition to its activation by ZAPS.
Lys63 (K63)-linked polyubiquitination of RIG-I mediated by the ubiquitin ligase TRIM25 represents another important modification that links RIG-I activation to MAVS 17 . Other mediators of protein modification, such as ISG15, RNF125, CYLD and Riplet (REUL), also have a regulatory role in RIG-I activation [49] [50] [51] [52] . In addition, unanchored K63-ubiquitin chains, which are not conjugated to any target protein, positively regulate RNA-triggered activation of RIG-I through their binding to RIG-I CARDs 16 . Our results support the idea that ZAPS functions as a RIG-I regulator upstream of the ubiquitin-mediated regulatory mechanisms, although further analyses are needed to clarify whether ZAPS participates in the ubiquitination of RIG-I.
AT-rich double-stranded DNA can be transcribed into 3pRNA by DNA-dependent RNA polymerase III, resulting in activation of RIG-I and production of type I interferon and activation of the NF-κB pathway 36, 37 . In this context, it can be presumed that ZAPS may also enhance cytosolic DNA-triggered cytokine induction through its positive regulation of RIG-I pathway. That possibility was supported by our preliminary observation that poly(dA:dT)-triggered induction of type I interferons was significantly abolished in HEK293T cells treated with siRNA targeting ZAPS (P < 0.01; S.H., S.S., H.Y. and A.T., unpublished data).
Our data showing that ZAPS was critically involved in antiviral innate immune responses to influenza virus and NDV raised the possibility that ZAPS may have an important role in host defense against many other viruses known to activate RIG-I signaling, such as Sendai virus, hepatitis C virus and Japanese encephalitis virus 45, 53 . Further investigation of the role of ZAPS in other virusactivated, PRR-mediated innate signaling is needed. In addition to the important role of ZAPS in RIG-I-mediated responses in human cells, we have preliminary data showing a function for ZAPS in several mouse cell lines (data not shown), although this remains to be further investigated.
ZAP has a role in the decay of mRNA derived from certain viral subsets 20, 26, 39 . Our data showing that ZAPS facilitated the activation of innate antiviral mechanisms indicate that ZAPS might exert a dual mode of defense activity against viral infection. These activities might be regulated differently through the ability of ZAPS to bind two distinct RNA helicases: RIG-I for the activation of host innate immune response, and p72 for the degradation of viral RNA 25, 26 . How these activities are regulated remains to be clarified. In addition, because of its dual antiviral function, activation of ZAPS could provide a therapeutic application aimed at enhancing antiviral responses.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
Note: Supplementary information is available on the Nature Immunology website.
